AG˹ٷ

STOCK TITAN

[8-K] Lexicon Pharmaceuticals, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Item 3.01 � Notice of Delisting Status. Vince Holding Corp. (NYSE: VNCE) disclosed that on 08/05/25 the NYSE accepted management’s remediation plan after the company breached Section 802.01B, which requires both a 30-day average market capitalization and stockholders� equity of � $50 million.

The exchange has granted a compliance window through 11/06/26 (the “Plan Period�). VNCE shares will remain listed and trade normally during this time, but the NYSE will conduct periodic reviews. Failure to achieve the $50 million thresholds or demonstrate satisfactory interim progress could trigger suspension and delisting proceedings.

Investor takeaways: acceptance removes the immediate delisting threat and preserves liquidity; however, the sub-$50 million valuation highlights significant capital-structure weakness. Management must execute operational improvements or raise capital before the deadline—success remains uncertain.

Voce 3.01 � Avviso di Rimozione dalla Quotazione. Vince Holding Corp. (NYSE: VNCE) ha comunicato che il 05/08/25 il NYSE ha accettato il piano di rimedio proposto dalla direzione dopo che la società ha violato la Sezione 802.01B, che richiede una capitalizzazione di mercato media a 30 giorni e un patrimonio netto degli azionisti entrambi � 50 milioni di dollari.

La borsa ha concesso un periodo di conformità fino al 06/11/26 (il “Periodo del Piano�). Le azioni VNCE rimarranno quotate e negoziate normalmente durante questo periodo, ma il NYSE effettuerà revisioni periodiche. Il mancato raggiungimento delle soglie di 50 milioni di dollari o la mancata dimostrazione di progressi intermedi soddisfacenti potrebbe innescare sospensioni e procedure di rimozione dalla quotazione.

Considerazioni per gli investitori: l’accettazione elimina la minaccia immediata di delisting e preserva la liquidità; tuttavia, la valutazione inferiore ai 50 milioni evidenzia una significativa debolezza nella struttura del capitale. La direzione deve attuare miglioramenti operativi o raccogliere capitale prima della scadenza � il successo resta incerto.

Artículo 3.01 � Aviso de Estado de Exclusión. Vince Holding Corp. (NYSE: VNCE) informó que el 05/08/25 la NYSE ó el plan de remediación de la dirección tras incumplir la Sección 802.01B, que exige un promedio de capitalización de mercado a 30 días y patrimonio neto de accionistas � 50 millones de dólares.

La bolsa ha otorgado un período de cumplimiento hasta el 06/11/26 (el “Período del Plan�). Las acciones de VNCE permanecerán listadas y se negociarán normalmente durante este tiempo, pero la NYSE realizará revisiones periódicas. El incumplimiento de los umbrales de 50 millones o la falta de progreso interino satisfactorio podría desencadenar suspensión y procedimientos de exclusión.

Conclusiones para inversores: la aceptación elimina la amenaza inmediata de exclusión y mantiene la liquidez; sin embargo, la valoración inferior a 50 millones destaca una debilidad significativa en la estructura de capital. La dirección debe implementar mejoras operativas o recaudar capital antes de la fecha límite—el éxito es incierto.

항목 3.01 � 상장폐지 통지. Vince Holding Corp. (NYSE: VNCE)� 2025� 8� 5� NYSE가 회사가 802.01B 조항� 위반� � 경영진의 개선 계획� 수락했다� 공시했습니다. 해당 조항은 30� 평균 시가총액� 주주 자본� 각각 5,000� 달러 이상이어� 함을 요구합니�.

거래소는 2026� 11� 6일까지(“계� 기간�) 준� 기간� 부여했습니�. � 기간 동안 VNCE 주식은 계속 상장되어 정상 거래되지�, NYSE� 정기적으� 검토를 실시� 예정입니�. 5,000� 달러 기준� 달성하지 못하거나 중간 진행 상황� 만족스럽지 않으� 거래 정지 � 상장폐지 절차가 개시� � 있습니다.

투자� 참고사항: 수락으로 즉각적인 상장폐지 위협� 해소되고 유동성이 유지되지�, 5,000� 달러 미만� 평가액은 자본 구조� 심각� 약점� 나타냅니�. 경영진은 마감� 전에 운영 개선� 실행하거� 자본� 조달해야 하며, 성공 여부� 불확실합니다.

Point 3.01 � Avis de Retrait de Cotation. Vince Holding Corp. (NYSE : VNCE) a annoncé que le 05/08/25, le NYSE a é le plan de redressement de la direction suite à la violation par la société de la section 802.01B, qui exige une capitalisation boursière moyenne sur 30 jours et des capitaux propres des actionnaires d’au moins 50 millions de dollars.

La bourse a accordé une période de conformité jusqu’au 06/11/26 (la « Période du Plan »). Les actions VNCE resteront cotées et négociées normalement pendant cette période, mais le NYSE effectuera des contrôles périodiques. Le non-respect des seuils de 50 millions de dollars ou l’absence de progrès intermédiaires satisfaisants pourrait entraîner une suspension et une procédure de retrait de cotation.

Points clés pour les investisseurs : l’acceptation supprime la menace immédiate de retrait et préserve la liquidité ; cependant, une valorisation inférieure à 50 millions souligne une faiblesse importante de la structure du capital. La direction doit mettre en œuvre des améliorations opérationnelles ou lever des fonds avant la date limite � le succès reste incertain.

Punkt 3.01 � Mitteilung über den Status der Delistung. Vince Holding Corp. (NYSE: VNCE) gab bekannt, dass die NYSE am 05.08.25 den Sanierungsplan des Managements akzeptiert hat, nachdem das Unternehmen gegen Abschnitt 802.01B verstoßen hatte, der sowohl eine 30-Tage-Durchschnitts-Marktkapitalisierung als auch ein Eigenkapital von � 50 Millionen Dollar verlangt.

Die Börse hat eine Frist zur Einhaltung bis zum 06.11.26 (die „Planperiode�) eingeräumt. Die VNCE-Aktien bleiben während dieser Zeit gelistet und werden regulär gehandelt, jedoch führt die NYSE regelmäßige Überprüfungen durch. Das Nichterreichen der 50-Millionen-Dollar-Grenzen oder das Ausbleiben zufriedenstellender Zwischenfortschritte könnte zu Aussetzung und Delisting-Verfahren führen.

Für Investoren: Die Akzeptanz beseitigt die unmittelbare Delisting-Gefahr und sichert die Liquidität; jedoch verdeutlicht die Bewertung unter 50 Millionen eine erhebliche Schwäche in der Kapitalstruktur. Das Management muss vor Ablauf der Frist operative Verbesserungen umsetzen oder Kapital beschaffen � der Erfolg ist ungewiss.

Positive
  • NYSE accepted VNCE’s compliance plan, allowing continued NYSE trading until 11/06/26 and buying management time to execute a turnaround.
Negative
  • Company remains out of compliance with the NYSE’s $50 million market-cap and equity requirements, maintaining a material delisting risk.
  • Sub-$50 million valuation underscores weak investor confidence and limits capital-raising flexibility.

Insights

TL;DR NYSE plan acceptance averts immediate delisting, but VNCE still under $50 m thresholds; impact neutral until management proves recovery.

The NYSE reprieve provides time for strategic actions—potential equity infusion, asset sales, or operational turnaround—to restore capital levels. Liquidity in the shares is preserved, limiting near-term trading disruption. Yet the underlying problem remains: a market cap and book equity below $50 m signal fundamental weakness. Until VNCE outlines concrete capital-raising steps or posts improving operating metrics, the event is best viewed as procedural rather than value-creating. I classify the filing as neutral for valuation but it maintains option value for a turnaround.

TL;DR Delisting risk persists; investors face liquidity, capital-raising and perception headwinds if plan fails.

While the acceptance letter pauses immediate enforcement, the company now operates under an NYSE microscope. Should market sentiment worsen or equity erosion continue, VNCE could breach additional listing rules, accelerating delisting. Such an outcome would hamper capital access and employee retention. The disclosure also signals potential going-concern pressures, warranting heightened credit and counterparty scrutiny. Overall, the risk profile has deteriorated versus compliant peers despite the temporary stay.

Voce 3.01 � Avviso di Rimozione dalla Quotazione. Vince Holding Corp. (NYSE: VNCE) ha comunicato che il 05/08/25 il NYSE ha accettato il piano di rimedio proposto dalla direzione dopo che la società ha violato la Sezione 802.01B, che richiede una capitalizzazione di mercato media a 30 giorni e un patrimonio netto degli azionisti entrambi � 50 milioni di dollari.

La borsa ha concesso un periodo di conformità fino al 06/11/26 (il “Periodo del Piano�). Le azioni VNCE rimarranno quotate e negoziate normalmente durante questo periodo, ma il NYSE effettuerà revisioni periodiche. Il mancato raggiungimento delle soglie di 50 milioni di dollari o la mancata dimostrazione di progressi intermedi soddisfacenti potrebbe innescare sospensioni e procedure di rimozione dalla quotazione.

Considerazioni per gli investitori: l’accettazione elimina la minaccia immediata di delisting e preserva la liquidità; tuttavia, la valutazione inferiore ai 50 milioni evidenzia una significativa debolezza nella struttura del capitale. La direzione deve attuare miglioramenti operativi o raccogliere capitale prima della scadenza � il successo resta incerto.

Artículo 3.01 � Aviso de Estado de Exclusión. Vince Holding Corp. (NYSE: VNCE) informó que el 05/08/25 la NYSE ó el plan de remediación de la dirección tras incumplir la Sección 802.01B, que exige un promedio de capitalización de mercado a 30 días y patrimonio neto de accionistas � 50 millones de dólares.

La bolsa ha otorgado un período de cumplimiento hasta el 06/11/26 (el “Período del Plan�). Las acciones de VNCE permanecerán listadas y se negociarán normalmente durante este tiempo, pero la NYSE realizará revisiones periódicas. El incumplimiento de los umbrales de 50 millones o la falta de progreso interino satisfactorio podría desencadenar suspensión y procedimientos de exclusión.

Conclusiones para inversores: la aceptación elimina la amenaza inmediata de exclusión y mantiene la liquidez; sin embargo, la valoración inferior a 50 millones destaca una debilidad significativa en la estructura de capital. La dirección debe implementar mejoras operativas o recaudar capital antes de la fecha límite—el éxito es incierto.

항목 3.01 � 상장폐지 통지. Vince Holding Corp. (NYSE: VNCE)� 2025� 8� 5� NYSE가 회사가 802.01B 조항� 위반� � 경영진의 개선 계획� 수락했다� 공시했습니다. 해당 조항은 30� 평균 시가총액� 주주 자본� 각각 5,000� 달러 이상이어� 함을 요구합니�.

거래소는 2026� 11� 6일까지(“계� 기간�) 준� 기간� 부여했습니�. � 기간 동안 VNCE 주식은 계속 상장되어 정상 거래되지�, NYSE� 정기적으� 검토를 실시� 예정입니�. 5,000� 달러 기준� 달성하지 못하거나 중간 진행 상황� 만족스럽지 않으� 거래 정지 � 상장폐지 절차가 개시� � 있습니다.

투자� 참고사항: 수락으로 즉각적인 상장폐지 위협� 해소되고 유동성이 유지되지�, 5,000� 달러 미만� 평가액은 자본 구조� 심각� 약점� 나타냅니�. 경영진은 마감� 전에 운영 개선� 실행하거� 자본� 조달해야 하며, 성공 여부� 불확실합니다.

Point 3.01 � Avis de Retrait de Cotation. Vince Holding Corp. (NYSE : VNCE) a annoncé que le 05/08/25, le NYSE a é le plan de redressement de la direction suite à la violation par la société de la section 802.01B, qui exige une capitalisation boursière moyenne sur 30 jours et des capitaux propres des actionnaires d’au moins 50 millions de dollars.

La bourse a accordé une période de conformité jusqu’au 06/11/26 (la « Période du Plan »). Les actions VNCE resteront cotées et négociées normalement pendant cette période, mais le NYSE effectuera des contrôles périodiques. Le non-respect des seuils de 50 millions de dollars ou l’absence de progrès intermédiaires satisfaisants pourrait entraîner une suspension et une procédure de retrait de cotation.

Points clés pour les investisseurs : l’acceptation supprime la menace immédiate de retrait et préserve la liquidité ; cependant, une valorisation inférieure à 50 millions souligne une faiblesse importante de la structure du capital. La direction doit mettre en œuvre des améliorations opérationnelles ou lever des fonds avant la date limite � le succès reste incertain.

Punkt 3.01 � Mitteilung über den Status der Delistung. Vince Holding Corp. (NYSE: VNCE) gab bekannt, dass die NYSE am 05.08.25 den Sanierungsplan des Managements akzeptiert hat, nachdem das Unternehmen gegen Abschnitt 802.01B verstoßen hatte, der sowohl eine 30-Tage-Durchschnitts-Marktkapitalisierung als auch ein Eigenkapital von � 50 Millionen Dollar verlangt.

Die Börse hat eine Frist zur Einhaltung bis zum 06.11.26 (die „Planperiode�) eingeräumt. Die VNCE-Aktien bleiben während dieser Zeit gelistet und werden regulär gehandelt, jedoch führt die NYSE regelmäßige Überprüfungen durch. Das Nichterreichen der 50-Millionen-Dollar-Grenzen oder das Ausbleiben zufriedenstellender Zwischenfortschritte könnte zu Aussetzung und Delisting-Verfahren führen.

Für Investoren: Die Akzeptanz beseitigt die unmittelbare Delisting-Gefahr und sichert die Liquidität; jedoch verdeutlicht die Bewertung unter 50 Millionen eine erhebliche Schwäche in der Kapitalstruktur. Das Management muss vor Ablauf der Frist operative Verbesserungen umsetzen oder Kapital beschaffen � der Erfolg ist ungewiss.

0001062822FALSE00010628222025-08-062025-08-06


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________

FORM 8-K
__________________

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 6, 2025

Lexicon Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Delaware000-3011176-0474169
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)(I.R.S. Employer
Identification Number)

2445 Technology Forest Blvd., 11th Floor
The Woodlands, Texas 77381
(Address of principal executive offices and Zip Code)

(281) 863-3000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001LXRX
The Nasdaq Capital Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 2.02     Results of Operation and Financial Condition

On August 6, 2025, we issued a press release to report our financial results for the quarter ended June 30, 2025. A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.

The information in this Form 8-K and the Exhibit attached to this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.


Item 9.01    Financial Statements and Exhibits

(d)    Exhibits

Exhibit No.Description
99.1
Press Release of Lexicon Pharmaceuticals, Inc. dated August 6, 2025
EX-104Cover Page Interactive Data File (embedded within the Inline XBRL document)




Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Lexicon Pharmaceuticals, Inc.
Date: August 6, 2025By:/s/ Brian T. Crum
Brian T. Crum
Senior Vice President and General Counsel




FAQ

Why did the NYSE notify VNCE of non-compliance?

Because VNCE’s 30-day average market capitalization and stockholders� equity both fell below the $50 million thresholds set in Section 802.01B.

How long does Vince Holding (VNCE) have to regain compliance?

Until November 6, 2026, the end of the NYSE-approved Plan Period.

Will VNCE shares continue trading during the Plan Period?

Yes. The Acceptance Letter states VNCE will remain listed on the NYSE provided it meets all other listing rules.

What happens if VNCE fails to meet NYSE requirements by Nov 6 2026?

The NYSE may begin suspension and delisting proceedings, which could significantly reduce liquidity and market visibility.

Does the NYSE decision change VNCE’s SEC reporting obligations?

No. The company must continue to file all required reports with the SEC.
Lexicon Pharmaceuticals Inc

NASDAQ:LXRX

LXRX Rankings

LXRX Latest News

LXRX Latest SEC Filings

LXRX Stock Data

381.34M
358.72M
1.17%
76.53%
8.04%
Biotechnology
Pharmaceutical Preparations
United States
THE WOODLANDS